Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

XAGE-2 Activators

The functional activity of XAGE-2 is enhanced by various chemical activators that operate through distinct signaling pathways, ensuring precise regulation and response within cellular environments. One class of these activators functions by modulating the levels of cyclic adenosine monophosphate (cAMP) within the cell. By either directly stimulating adenylyl cyclase or inhibiting the degradation of cAMP by phosphodiesterases, these activators ensure a sustained and elevated concentration of cAMP, a crucial secondary messenger. The increase in cAMP levels leads to the activation of protein kinase A (PKA), which then phosphorylates target proteins, resulting in a cascade of signaling events that ultimately enhance the activity of XAGE-2. Additionally, the introduction of cAMP analogs resistant to degradation acts in a similar manner to bolster cellular PKA activity, further amplifying the signaling that converges on the activation of XAGE-2.

Complementary to cAMP-mediated mechanisms, the intracellular concentration of calcium ions also plays a pivotal role in the activation of XAGE-2. Certain activators, functioning as ionophores, facilitate the influx of calcium into the cytoplasm, thereby elevating intracellular calcium levels and triggering calcium-dependent protein kinases. These kinases are instrumental in transducing signals that lead to the activation of XAGE-2. Moreover, the generation of nitric oxide and subsequent activation of guanylyl cyclase culminates in increased levels of cyclic guanosine monophosphate (cGMP). The rise in cGMP levels, much like cAMP, activates a specific set of protein kinases that contribute to the regulatory control of XAGE-2 activity.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

L-Arginine

74-79-3sc-391657B
sc-391657
sc-391657A
sc-391657C
sc-391657D
5 g
25 g
100 g
500 g
1 kg
$20.00
$30.00
$60.00
$215.00
$345.00
2
(0)

Precursor of nitric oxide synthesis, whose product can activate guanylyl cyclase and increase cGMP levels, indirectly enhancing XAGE-2 activity through cGMP-dependent protein kinases.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

A selective inhibitor of phosphodiesterases 5, 6, and 9, leading to increased cGMP levels potentially activating XAGE-2 through cGMP-dependent signaling pathways.